Efficacy

Efficacy Studies:

A study comparing the effects of Esketamine therapy taken alongside another oral antidepressant showed greater improvement in depressive symptoms when compared to those taking a placebo alongside an oral antidepressant –

A study comparing the effects and remission rates of TRD while taking Esketamine (Spravato) vs. an oral antipsychotic show that patients with a diagnosis of TRD undergoing Esketamine therapy were 65% more likely to achieve remission at Week 8 when compared to those taking the antipsychotic alone

Become A Patient